Press release
Uterine Cancer Diagnostic Testing Market to Touch US$ 3.8 Bn by 2026 End
In a recent study on the global uterine cancer diagnostic testing market, leading research firm Persistence Market Research has tracked the growth path of the global market for uterine cancer diagnostic testing over an eight year period from 2018 to 2026. The report features global market numbers and insights on the various factors driving the adoption of advanced uterine cancer diagnostic tests. According to the report, two of the main aspects responsible for a surge in revenue in the global uterine cancer diagnostic testing market are - a rising awareness among the female population pertaining to the various diseases of the uterus, and the availability of different types of direct and combination tests to detect uterine cancer.
Persistence Market Research forecasts revenue in the global uterine cancer diagnostic testing market to reach around US$ 3.8 Bn by 2026 end, up from an estimated value of about US$ 2 Bn in 2018. The market is expected to witness a growth rate of 7.8% during the eight year period from 2018 to 2026.
Numerous Tumor Marker Tests Currently Used to Detect Uterine Cancer to Provide a Wide Window of Opportunity in the Global Market
Request Sample Report@ https://www.persistencemarketresearch.com/samples/17005
Persistence Market Research analysis indicates that the glycoproteins CA19.9, YKL-40, CA72.4, and CA15.3 are useful markers that help in the diagnosis of patients suffering from endometrial cancer and may provide a wide opportunity as advanced and improved tumor marker tests for uterine cancer diagnostic testing in the coming years. Early detection of endometrial cancer in women with irregular and post-menopausal bleeding (one of the early symptoms of endometrial carcinoma) is also likely to elevate the market for uterine cancer diagnostic testing. BRCA1 and BRCA2 breast cancer mutations are related to the spread of endometrial cancer in women. Ongoing research studies that have linked uterine cancer and BRCA mutation indicate favorable outcomes for early-stage diagnosis and prevention of endometrial cancer, by suggesting a uterine diagnosis post the diagnosis of BRCA1 mutation. This is also anticipated to be a good opportunity area in the uterine cancer diagnostic testing market in the near future.
Genetics and Epigenetics Trending the Global Uterine Cancer Diagnostic Testing Market
Gene mutations are fast emerging as candidates in the carcinogenesis of endometrial carcinoma and uterine sarcoma. Gene mutations -- including K-ras mutations, PTEN, and β-catenin -- are being studied for the diagnosis of uterine cancer. Epigenetic factors such as DNA methylation and histone modification are also being studied to improve the rate of uterine cancer diagnosis. Advanced genetics and epigenetics are the latest trends being observed in the uterine cancer diagnostic testing market. Another trend is the age standardization of the women population that can help differentiate women from a specific age group who are more prone to developing tumors that may lead to uterine cancer.
A Favorable Reimbursement Scenario to Augur Well for the Global Uterine Cancer Diagnostic Testing Market
Improved reimbursement for uterine cancer diagnostic testing services with co-payment models based on the levels of income of people is a positive development in the global market for uterine cancer diagnostic testing. For instance, Medicare offers good reimbursements for uterine cancer diagnostic testing in the U.S. The governments across countries in North America have implemented co-payment reimbursement models that can be adjusted as per the income levels of the population. This is benefiting the global uterine cancer diagnostic testing market.
Request TOC@ https://www.persistencemarketresearch.com/methodology/17005
Key Research Findings on the Uterine Cancer Diagnostic Testing Market
Persistence Market Research throws light on the top regional growth markets for uterine cancer diagnostic testing; the most prevalent type of uterine cancer; the widely accepted test type to diagnose uterine cancer; and top end users in the uterine cancer diagnostic testing market in this comprehensive research study.
North America to remain leading regional market for uterine cancer diagnostic testing, holding over 40% market share by 2026
Endometrial carcinoma expected to be the most prevalent cancer type
Abdominal ultrasound, hysteroscopy, and CA-125 tumor marker blood test to remain most preferred test type
Diagnostic laboratories anticipated to be the top end users
ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uterine Cancer Diagnostic Testing Market to Touch US$ 3.8 Bn by 2026 End here
News-ID: 1259929 • Views: …
More Releases from Persistence Market Research
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview:
The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period.
Market Size and Growth:
The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and…
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction
Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities.
Get Access To…
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview:
The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033.
The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an…
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products.
To obtain the latest market…
More Releases for Uterine
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape.
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers…
Uterine Leiomyoma (Uterine Fibroids) Market: Global Industry Size, Share, Growth …
Latest industry research report on: Global Uterine Leiomyoma Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts.
DelveInsight's,Uterine Leiomyoma (Uterine Fibroids)-Global API Manufacturers,Marketed and Phase III Drugs Landscape,2018" report provides comprehensive insights about marketed and Phase III products for Uterine Leiomyoma (Uterine Fibroids) . The report includes information of marketed products including their product description,patent details,forecasted sales till 2020 & API manufacturer details by country.
Global API…
Uterine Leiomyoma (Uterine Fibroids)-Drugs Analysis, Market Trends and Forecast …
The various complications of uterine leiomyoma such as discomfort and complications such as anemia from heavy blood loss require the early detection and proper medication. Varying environmental factors such as birth control; vitamin D deficiency; obesity; and drinking alcohol, including beer, appear to increase the risk of developing fibroids. To discuss the market insight in-depth, Market Research Hub (MRH) has lately added a research study titled as “Uterine Leiomyoma (Uterine…
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2017”. Uterine fibroids are benign tumors that originate in the uterus (womb). Although they are composed of the same smooth muscle fibers as the uterine wall (myometrium), they are much denser than normal myometrium.
Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246573
Uterine fibroids are usually round. The most common…
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort.
According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to…
